BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 36765597)

  • 1. Follicular Thyroid Adenoma and Follicular Thyroid Carcinoma-A Common or Distinct Background? Loss of Heterozygosity in Comprehensive Microarray Study.
    Borowczyk M; Dobosz P; Szczepanek-Parulska E; Budny B; Dębicki S; Filipowicz D; Wrotkowska E; Oszywa M; Verburg FA; Janicka-Jedyńska M; Ziemnicka K; Ruchała M
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in Mutational Profile between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma Identified Using Next Generation Sequencing.
    Borowczyk M; Szczepanek-Parulska E; Dębicki S; Budny B; Verburg FA; Filipowicz D; Więckowska B; Janicka-Jedyńska M; Gil L; Ziemnicka K; Ruchała M
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31248021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues.
    Pfeifer A; Wojtas B; Oczko-Wojciechowska M; Kukulska A; Czarniecka A; Eszlinger M; Musholt T; Stokowy T; Swierniak M; Stobiecka E; Rusinek D; Tyszkiewicz T; Kowal M; Jarzab M; Hauptmann S; Lange D; Paschke R; Jarzab B
    BMC Med Genomics; 2013 Oct; 6():38. PubMed ID: 24099521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues.
    Sheikholeslami S; Shabani N; Shivaee S; Tavangar SM; Yeganeh M; Hedayati M; Lotfi J; Gholami H
    Mol Cell Probes; 2020 Jun; 51():101536. PubMed ID: 32081771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma.
    Jung SH; Kim MS; Jung CK; Park HC; Kim SY; Liu J; Bae JS; Lee SH; Kim TM; Lee SH; Chung YJ
    Oncotarget; 2016 Oct; 7(43):69638-69648. PubMed ID: 27626165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of six ultrasound-based risk stratification systems in thyroid follicular neoplasm: A retrospective multi-center study.
    Yang J; Sun Y; Li X; Zhao Y; Han X; Chen G; Ding W; Li R; Wang J; Xiao F; Liu C; Xu S
    Front Oncol; 2022; 12():1013410. PubMed ID: 36338713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of GPER1, EGFR and CXCR1 in differentiating between malignant follicular thyroid carcinoma and benign follicular thyroid adenoma.
    Zhao L; Zhu XY; Jiang R; Xu M; Wang N; Chen GG; Liu ZM
    Int J Clin Exp Pathol; 2015; 8(9):11236-47. PubMed ID: 26617848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray analysis of formalin-fixed, paraffin-embedded follicular thyroid carcinoma samples from patients who developed postoperative distant metastasis.
    Jikuzono T; Ishikawa T; Hirokawa M; Sugitani I; Ishibashi O
    BMC Res Notes; 2020 May; 13(1):241. PubMed ID: 32404135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma.
    Hossain MA; Asa TA; Rahman MM; Uddin S; Moustafa AA; Quinn JMW; Moni MA
    Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32093341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Ultrasound and Ultrasound-Based Prediction Model in Differentiating Follicular Thyroid Carcinoma From Follicular Thyroid Adenoma.
    Zhang F; Mei F; Chen W; Zhang Y
    J Ultrasound Med; 2024 Apr; ():. PubMed ID: 38577871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1].
    Tang QS; Teng XD; Ding W; Zhou J; Yao HT; Ying LX; Xu LM
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):745-8. PubMed ID: 22336157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of single-nucleotide polymorphism in TERT promoter on follicular thyroid tumor development.
    Hirokawa T; Arimasu Y; Nakazato Y; Chiba T; Fujiwara M; Kamma H
    Pathol Int; 2020 Apr; 70(4):210-216. PubMed ID: 31943533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutation of RAS gene in follicular-differentiated thyroid tumors and its significance].
    Liu LP; Hao JY; Pan H; Wang C; Yue P
    Zhonghua Bing Li Xue Za Zhi; 2020 Mar; 49(3):256-261. PubMed ID: 32187898
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultrasonic identification and regression analysis of 294 thyroid follicular tumors.
    Ou D; Yao J; Jin J; Yan M; Shi K; Zheng Q; Yang C; Xu D
    J Cancer Res Ther; 2020 Sep; 16(5):1056-1062. PubMed ID: 33004747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell.
    Migdalska-Sęk M; Czarnecka KH; Kusiński M; Pastuszak-Lewandoska D; Nawrot E; Kuzdak K; Brzeziańska-Lasota E
    Mol Diagn Ther; 2019 Jun; 23(3):369-382. PubMed ID: 30747408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours.
    Wojtas B; Pfeifer A; Oczko-Wojciechowska M; Krajewska J; Czarniecka A; Kukulska A; Eszlinger M; Musholt T; Stokowy T; Swierniak M; Stobiecka E; Chmielik E; Rusinek D; Tyszkiewicz T; Halczok M; Hauptmann S; Lange D; Jarzab M; Paschke R; Jarzab B
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28574441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.
    Marques AR; Espadinha C; Catarino AL; Moniz S; Pereira T; Sobrinho LG; Leite V
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3947-52. PubMed ID: 12161538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
    Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
    Wang N; Liu T; Sofiadis A; Juhlin CC; Zedenius J; Höög A; Larsson C; Xu D
    Cancer; 2014 Oct; 120(19):2965-79. PubMed ID: 24898513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors.
    Zhang JS; Nelson M; McIver B; Hay ID; Goellner JR; Grant CS; Eberhardt NL; Smith DI
    Oncogene; 1998 Aug; 17(6):789-93. PubMed ID: 9715281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.